Fig. 3.

a–c Expected reduction in adverse outcomes after changes in SpO₂ ranges. The following question was posed: Which of the following outcomes do you expect to be reduced with the new saturation targeting policy? Participants were asked to respond through a scale with 1 indicating very improbable and 5 indicating very probable. For analysis of this question, responses were divided into three groups: a NICUs using a lower limit of 86–88% and an upper limit ≤94% (n = 22), b NICUs using a range of 88–95% (n = 19), and c NICUs using a lower limit of 90–91% and an upper limit of 95% (n = 55). Neuro neurodevelopmental impairment. d Opinion on the strength of scientific evidence. The following question was posed: In your opinion, how strong is the scientific evidence supporting the beneficial/harmful effects of the oxygen saturation targeting policy that you are currently using in your NICU for infants born at ≤28 weeks gestation? (scale with 1 indicating very weak and 5 indicating very strong)